83 related articles for article (PubMed ID: 3559161)
1. Depot neuroleptics and manic depressive psychosis.
Lowe MR; Batchelor DH
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():53-62. PubMed ID: 3559161
[TBL] [Abstract][Full Text] [Related]
2. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
Malempati RN; Bond DJ; Yatham LN
Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
Gelders YG
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
arap Mengech HN; Wazome EG
East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
[No Abstract] [Full Text] [Related]
5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
6. Depot antipsychotic medications in bipolar disorder: a review of the literature.
Bond DJ; Pratoomsri W; Yatham LN
Acta Psychiatr Scand Suppl; 2007; (434):3-16. PubMed ID: 17688458
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
8. Rapid cycling disorders and the role of combined lithium and haloperidol decanoate.
Loew MR
Can J Psychiatry; 1986 Dec; 31(9):877-8. PubMed ID: 3542181
[No Abstract] [Full Text] [Related]
9. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
10. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
[TBL] [Abstract][Full Text] [Related]
11. Flupenthixol versus haloperidol in acute psychosis.
Parent M; Toussaint C
Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
[TBL] [Abstract][Full Text] [Related]
12. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
Cesková E; Svestka J; Rysánek R
Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
[TBL] [Abstract][Full Text] [Related]
13. Experience with depot neuroleptics in ambulatory practice.
Fiolet J
Acta Psychiatr Belg; 1981; 81(2):182-8. PubMed ID: 6117188
[TBL] [Abstract][Full Text] [Related]
14. Case report: manic depressive psychosis following infectious mononucleosis.
Goldney RD; Temme PB
J Clin Psychiatry; 1980 Sep; 41(9):322-3. PubMed ID: 7410328
[TBL] [Abstract][Full Text] [Related]
15. The use of depot neuroleptic haloperidol decanoate.
Fernando J; Krishna Raju R; Jones GG; Stanley RO
Acta Psychiatr Scand; 1984 Feb; 69(2):175-6. PubMed ID: 6702478
[TBL] [Abstract][Full Text] [Related]
16. The effect of haloperidol on serum levels of lithium in adult manic patients.
Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC
Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
[No Abstract] [Full Text] [Related]
17. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
18. Lithium combined with carbamazepine or haloperidol in the treatment of mania.
Small JG; Klapper MH; Marhenke JD; Milstein V; Woodham GC; Kellams JJ
Psychopharmacol Bull; 1995; 31(2):265-72. PubMed ID: 7491378
[TBL] [Abstract][Full Text] [Related]
19. Violent and self-injurious behaviour in mentally handicapped patients--psychopharmacological control.
Read SG; Batchelor DH
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():63-74. PubMed ID: 3559162
[TBL] [Abstract][Full Text] [Related]
20. Antimanic effect of clonazepam.
Chouinard G; Young SN; Annable L
Biol Psychiatry; 1983 Apr; 18(4):451-66. PubMed ID: 6407539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
